Lawrence Feldman
Hematology & Oncology · Chicago, ILNPI 1871607051
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $168 of the $270 with a category attached, or 62.3%. 10 manufacturers reported payments, led by AstraZeneca at 25.4% of the total. 2025 is the largest year on record at $89, more than ten times the $8 reported in 2020. That places this record below the midpoint for hematology & oncology clinicians in IL, where the typical reported total is $2,365.
Across 12 payments — averaging $22.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$68
- Merck$44
- Takeda Pharmaceuticals U.S.A., Inc.$25
- Genentech USA, Inc.$25
- EMD Serono, Inc.$22
- Tempus AI, Inc$21
- plus $65 from 4 others
Across 115 payments — averaging $15,193 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$1.2M
- E.r. Squibb & Sons, L.L.C.$132K
- Incyte Corporation$98K
- Novocure Inc.$87K
- Genentech, Inc.$66K
- Array Biopharma Inc$41K
- plus $133K from 5 others
What the payments were for
- Food & beverage$16862%
- Education$10238%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 1 | $68 |
| Merck | 3 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $25 |
| EMD Serono, Inc. | 1 | $22 |
| Tempus AI, Inc | 1 | $21 |
| Seagen Inc. | 1 | $20 |
| Deciphera Pharmaceuticals Inc. | 1 | $18 |
| Exelixis Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $11 |
How this compares
$270 in reported general payments places this provider in the 20th percentile of 580 hematology & oncology providers in Illinois.
Other hematology & oncology in Chicago
- Michael BishopChicago$974K
- Jamile ShammoChicago$910K
- Young Kwang ChaeChicago$563K
- Irfan MirzaChicago$544K
- Marina GarassinoChicago$397K
- Chih-Yi LiaoChicago$317K
- Rita NandaChicago$286K
- Shuo MaChicago$280K
- Santosh SarafChicago$275K
- Peter RiedellChicago$273K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.